Main Session
Sep
29
SS 41 - Optimizing Radiation Therapy in Gynecologic Cancers: Fractionation, Targeting, and Toxicity Reduction
324 - Hypofractionated IMRT and Weekly Cisplatin in Patients with Stage IIB and IIIB-C1 Cervix Cancer: A Phase I/II Study - The HYPOTHESIS Trial
Presenter(s)
Heloisa de Andrade Carvalho, MD, PhD - University of São Paulo and Hospital Sírio-Libanês, Sao Paulo, Sao Paulo